Xiangqian Qi Selected Research

Xiangqian Qi Research Topics

3	Myocardial Infarction 08/2018 - 01/2015
3	Ventricular Fibrillation 05/2014 - 01/2002
2	Ischemic Stroke 01/2021 - 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019
1	Cerebral Small Vessel Diseases 01/2019
1	Thrombosis (Thrombus) 08/2018
1	Death (Near-Death Experience) 08/2018
1	Glioma (Gliomas) 03/2018
1	Neoplasms (Cancer) 03/2018
1	Atherosclerosis 01/2018
1	Acute Coronary Syndrome 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2015
1	Coronary Disease (Coronary Heart Disease) 01/2015
1	Ventricular Tachycardia 05/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 05/2014
1	Ischemia 05/2014
1	Cerebral Hemorrhage 07/2013
1	Hemorrhagic Stroke 07/2013
1	Diabetes Mellitus 11/2012
1	Renal Insufficiency (Renal Failure) 11/2012

2	MicroRNAs (MicroRNA)IBA 08/2021 - 01/2018
2	BariumIBA 02/2002 - 01/2002
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	25-hydroxyvitamin DIBA 01/2019
1	hydroxide ionIBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	Biological ProductsIBA 03/2018
1	proto-oncogene protein Spi-1IBA 03/2018
1	Transcription Factors (Transcription Factor)IBA 03/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	ButyrylcholinesteraseIBA 01/2016
1	zotarolimusIBA 01/2015
1	Everolimus FDA Link 01/2015
1	Connexin 43 (Connexin43)IBA 05/2014
1	Heptanol (1 Heptanol)IBA 05/2014
1	HDL CholesterolIBA 07/2013
1	LDL CholesterolIBA 07/2013
1	CholesterolIBA 07/2013
1	iopromide (Ultravist)FDA Link 11/2012
1	iodixanol (Visipaque)FDA Link 11/2012
1	terikalantIBA 02/2002
1	Sotalol (Sotalol Hydrochloride)FDA LinkGeneric 01/2002

2	Stents 08/2018 - 01/2015
1	Percutaneous Coronary Intervention 01/2015
1	Ligation 05/2014